Funder: Pfizer Inc.
Due Dates: May 21, 2026 (Submission deadline, full application)
Funding Amounts: Up to $100,000 per project; project duration up to 12 months; total available budget is $100,000.
Summary: Supports independent medical education projects to enhance healthcare professionals’ understanding and application of generic JAK inhibitors in rheumatologic disease management.
Key Information: Applications submitted after the deadline will not be reviewed; only organizations (not individuals) are eligible.